These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640 [TBL] [Abstract][Full Text] [Related]
3. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Helmes AW; Culver JO; Bowen DJ Patient Educ Couns; 2006 Dec; 64(1-3):96-103. PubMed ID: 16427245 [TBL] [Abstract][Full Text] [Related]
4. Patients' resistance to risk information in genetic counseling for BRCA1/2. Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527 [TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. Calzone KA; Prindiville SA; Jourkiv O; Jenkins J; DeCarvalho M; Wallerstedt DB; Liewehr DJ; Steinberg SM; Soballe PW; Lipkowitz S; Klein P; Kirsch IR J Clin Oncol; 2005 May; 23(15):3455-64. PubMed ID: 15908654 [TBL] [Abstract][Full Text] [Related]
6. Participation in breast cancer risk counseling among women with a family history. Bowen D; McTiernan A; Burke W; Powers D; Pruski J; Durfy S; Gralow J; Malone K Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):581-5. PubMed ID: 10428194 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Antoniou AC; Durocher F; Smith P; Simard J; Easton DF; Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652 [TBL] [Abstract][Full Text] [Related]
8. Development of the breast cancer education and risk assessment program. Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593 [TBL] [Abstract][Full Text] [Related]
9. Risk perception among women receiving genetic counseling: a population-based follow-up study. Mikkelsen EM; Sunde L; Johansen C; Johnsen SP Cancer Detect Prev; 2007; 31(6):457-64. PubMed ID: 18061369 [TBL] [Abstract][Full Text] [Related]
10. Hereditary breast-ovarian cancer: clinical findings and medical management. Marshall M; Solomon S Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820 [TBL] [Abstract][Full Text] [Related]
11. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788 [TBL] [Abstract][Full Text] [Related]
12. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium. Rimer BK; Schildkraut JM; Lerman C; Lin TH; Audrain J Cancer; 1996 Jun; 77(11):2348-55. PubMed ID: 8635106 [TBL] [Abstract][Full Text] [Related]
13. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations. Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821 [TBL] [Abstract][Full Text] [Related]
14. Direct-to-patient BRCA1 testing: the Twoj Styl experience. Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675 [TBL] [Abstract][Full Text] [Related]
15. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254 [TBL] [Abstract][Full Text] [Related]
16. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk elements and nurse practitioners' knowledge, use, and perceived comfort level of breast cancer risk assessment. Edwards QT; Maradiegue A; Seibert D; Saunders-Goldson S; Humphreys S J Am Acad Nurse Pract; 2009 May; 21(5):270-7. PubMed ID: 19432911 [TBL] [Abstract][Full Text] [Related]
18. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing. Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345 [TBL] [Abstract][Full Text] [Related]
19. Risk assessment of first-degree relatives of women with breast cancer: a feasibility study. Hurt GJ; McQuellon RP; Michielutte R; Conrad DM; Carter S; Anderson H Oncol Nurs Forum; 2001 Aug; 28(7):1097-104. PubMed ID: 11517843 [TBL] [Abstract][Full Text] [Related]
20. How making a risk estimate can change the feel of that risk: shifting attitudes toward breast cancer risk in a general public survey. Fagerlin A; Zikmund-Fisher BJ; Ubel PA Patient Educ Couns; 2005 Jun; 57(3):294-9. PubMed ID: 15893211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]